Meeting/Event Information

 
Healthcare in the 21st century is coming to embrace advanced technologies in an effort to shift toward more individualized, patient centered and value based approaches that will focus on quality improvement and outcomes measurements. Consequently, it is essential that cardiovascular clinicians not only understand disease and wellness states, but be able to competently and appropriately implement new diagnostic and therapeutic modalities.

Overall Goal

The overall goal of this program is to help the cardiovascular clinician improve patient care and outcomes measurements. Specifically, we anticipate that cardiovascular clinicians will be able to identify knowledge and practice gaps and that the knowledge gained will result in improved clinical expertise and patient care.

Target Audience

This course is designed for Cardiologists, CV Surgeons, Pharmacists, Cardiovascular Physician Trainees, Internists, Primary Care Physicians, Physician Assistants, Nurse Practitioners, and other health care providers.

Learning Objectives

• Discuss the role of innovation and the impact on quality cardiovascular patient care.

• Be familiar with current guidelines used in the diagnosis and management of aortic disease, atrial fibrillation and hypertrophic cardiomyopathy.

• Discuss factors in selecting and using medications effectively in cardiovascular patients.

• Be able to identify and discuss a variety of patient care strategies, including pharmacologic, in the management of patients with various disease states and conditions.

Fees include enrollment, continuing education credits, educational materials, continental breakfast, refreshment breaks, and lunch. If your hospital is sponsoring the meeting, please register with your complimentary meeting code.

Cardiology Fellows may attend course at no charge. Please email a letter from your Fellowship Training Director indicating your status as a trainee to [email protected].

View the Meeting Brochure.

Interested in being an exhibitor? View the Exhibitor Prospectus.